ERC Workshop to Address Health and Safety of the Temporary Workforce
On April 7, the Education and Research Center (ERC) at the University of Cincinnati (UC) will host a day-long topical workshop titled "Health and Safety of Temporary Workers. The program will run from 8:30 a.m. to 4:30 p.m. at the College of Nursing (Procter Hall) and is free and open to the public.
In three moderated sessions, the workshop will feature speakers from the National Institute for Occupational Safety and Health (NIOSH), the Cincinnati Occupational Safety and Health Administration (OSHA) and the International Chemical Workers Union Council, as well as researchers presenting on ways to improve worker health and safety.
"This topical workshop aims to provide an overview on the current health and safety of temporary workers and will address the recent development and challenges in this field, says Tiina Reponen, PhD, professor and director of UCs ERC.
The program is designed for occupational health and safety professionals, ERC students and faculty. Advocates for temporary workers or any other professionals who work with the temporary workforce are also welcome to attend.
The workshop offers continuing education for American Board of Industrial Hygiene (ABIH), Board of Certified Safety Professionals (BCSP) and Nursing CEU contact hours. Online registration is open until April 1.
The UC ERC serves regional and national needs in occupational safety and health through interdisciplinary academic education, research training and a wide range of continuing education courses are available for practicing professionals. In partnership with ERCs at the University of Illinois at Chicago, and the University of Michigan, the program will be offered as a webinar broadcast onsite at these partner institutions.
The workshop is supported by NIOSH and by the student chapters of the American Industrial Hygiene Association and American Society of Safety Engineers.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.